Search

Penumbra Inc

Nyitva

SzektorEgészségügy

324.17 0.13

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

322.7

Maximum

324.57

Fő mutatók

By Trading Economics

Bevétel

2.2M

35M

Értékesítés

15M

390M

P/E

Szektor átlag

80.584

57.371

Egy részvényre jutó nyereség

0.88

Profit margin

8.925

Munkavállalók

4,700

EBITDA

5.5M

52M

Ajánlások

By TipRanks

Ajánlások

Semleges

12 hónapos előrejelzés

+10.22% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 4.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

321M

13B

Előző nyitás

324.04

Előző zárás

324.17

Hangulat hírek alapján

By Acuity

50%

50%

147 / 340 Rangsor szerint Healthcare

Penumbra Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 22. 00:02 UTC

Penumbra Inc shares are higher in after-market hours, rebounding alongside major stocks and remaining above the 20-day moving average. No specific news was identified.

2026. aug. 21. 23:31 UTC

Penumbra Inc's shares are higher in after-market trading, rebounding from an initial decline. The stock is above its 20-day moving average.

2026. aug. 17. 19:36 UTC

Correlated Moves

Penumbra Inc. shares are lower today, reflecting broader market declines amid rising bond yields and geopolitical tensions. The stock is near its one-month range high.

2026. aug. 10. 19:36 UTC

Correlated Moves

Penumbra Inc shares are higher today, supported by positive trends in the health care equipment sector and the performance of related ETFs.

2026. aug. 8. 00:02 UTC

Penumbra Inc shares are trading higher in after-market hours, maintaining strength above the 20-day moving average and near the upper end of their one-month range.

2026. aug. 7. 19:56 UTC

Penumbra Inc. shares are lower today, despite earlier gains, amid a broader market influenced by a disappointing jobs report and shifting monetary policy sentiment.

2026. aug. 6. 19:36 UTC

Penumbra Inc shares are modestly higher today, maintaining an upward trajectory. No specific company news was identified to explain the price movement.

2026. aug. 5. 21:03 UTC

Penumbra Inc shares are higher in after-market hours, though no specific news explains the movement. The stock remains above its 20-day moving average.

2026. aug. 4. 19:36 UTC

Penumbra Inc shares are higher today, reflecting a slight gain since Monday. The stock remains above its 20-day moving average amid broader market trends.

2026. aug. 3. 21:01 UTC

Penumbra Inc. shares are lower in after-market trading, despite gains in the broader market. The decline began shortly after Monday's close.

2026. júl. 24. 16:36 UTC

Correlated Moves

Penumbra Inc's shares are higher today, supported by gains in the medical devices sector and a decline in oil prices easing inflation concerns.

Társak összehasonlítása

Árváltozás

Penumbra Inc Előrejelzés

Célár

By TipRanks

10.22% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 358.4 USD  10.22%

Magas 374 USD

Alacsony 320 USD

6 Wall Street elemző 12 hónapos célárain alapulva a(z)Penumbra Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Semleges

6 ratings

1

Vétel

5

Tartás

0

Eladás

Hangulat

By Acuity

147 / 340 Rangsor szerint Egészségügy

Hangulat hírek alapján

Neutral

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat